Koutts J, Lavergne J M, Meyer D
Br J Haematol. 1977 Nov;37(3):415-28. doi: 10.1111/j.1365-2141.1977.tb01013.x.
The relationship between the three measurable components of the factor VIII complex, procoagulant activity (VIII:C), Ristocetin cofactor (VIIIR:WF) and factor VIII related antigen (VIIR:AG), has been investigated using a solid phase immunoadsorption system in which homologous antibodies specific for VIII:C are insolubilized onto Sepharose beads. The VIII:C component of partially purified factor VIII can be completely separated from the Willebrand factor (VIIIR:WF/VIIIR:AG) by this technique. The loss of VIII:C has no detectable effect on the molecular size, antigenicity or electrophoretic mobility of the original molecule. The Willebrand factor (WF) recovered from these immunoadsorption columns was used to absorb heterologous antisera to factor VIII. A specific heterologous antiserum to VIII:C, which no longer neutralized VIIIR:WF nor precipitated VIIIR:AG, was obtained. Heterologous antisera to WF were prepared which potently neutralized VIIR:WF and precipitated with VIIIR:AG, but also weakly neutralized VIII:C (titre I u/ml). This study is compatible with the theory that VIII:C and VIIIR:WF/VIIIR:AG are two different but linked entities.
利用一种固相免疫吸附系统,对凝血因子VIII复合物的三个可测量成分,即促凝活性(VIII:C)、瑞斯托霉素辅因子(VIIIR:WF)和凝血因子VIII相关抗原(VIIR:AG)之间的关系进行了研究。在该系统中,针对VIII:C的同源抗体被固定在琼脂糖珠上。通过这种技术,部分纯化的凝血因子VIII的VIII:C成分可以与血管性血友病因子(VIIIR:WF/VIIIR:AG)完全分离。VIII:C的缺失对原始分子的分子大小、抗原性或电泳迁移率没有可检测到的影响。从这些免疫吸附柱中回收的血管性血友病因子(WF)用于吸收针对凝血因子VIII的异种抗血清。获得了一种针对VIII:C的特异性异种抗血清,它不再中和VIIIR:WF,也不再沉淀VIIIR:AG。制备了针对WF的异种抗血清,它能有效中和VIIR:WF并与VIIIR:AG沉淀,但也能微弱中和VIII:C(效价为1单位/毫升)。这项研究与VIII:C和VIIIR:WF/VIIIR:AG是两个不同但相互关联的实体这一理论相符。